Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arete Therapeutics Inc.

http://www.aretetherapeutics.com

Latest From Arete Therapeutics Inc.

Lilly Adds To Radiopharma Arsenal With Option To Buy Radionetics

Lilly paid $140m up front for an option to acquire Radionetics for $1bn within an undisclosed timeframe. The private firm is developing small molecule GPCR-targeted radiopharmaceuticals.

Deals Cancer

Lilly Inks Follow-Up Radiopharmaceuticals Deal With Aktis

The big pharma will pay $60m upfront and make an equity investment in the Boston-based startup.

Deals Cancer

How To Grow A Biotech - Insights From Scientist-Entrepreneurs

Laura Soucek, a former In Vivo Rising Leader, and her co-founder have built their biotech, Peptomyc, around a previously undruggable target. They spoke about successes and learnings as scientist-entrepreneurs at BioEurope Spring.

Innovation Rising Leaders

Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators

Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.

Minute Insights Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register